about
What to Do, and What Not to Do, When Diagnosing and Treating Breakthrough Cancer Pain (BTcP): Expert OpinionOral transmucosal fentanyl citrate in cancer pain management: a practical application of nanotechnologyA new transmucosal drug delivery system for patients with breakthrough cancer pain: the fentanyl effervescent buccal tablet.
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
name
Management of breakthrough pain due to cancer.
@ast
Management of breakthrough pain due to cancer.
@en
type
label
Management of breakthrough pain due to cancer.
@ast
Management of breakthrough pain due to cancer.
@en
prefLabel
Management of breakthrough pain due to cancer.
@ast
Management of breakthrough pain due to cancer.
@en
P1433
P1476
Management of breakthrough pain due to cancer
@en
P2093
Simmonds MA
P304
1103-8; discussion 1110, 1113-4
P577
1999-08-01T00:00:00Z